Kevin E. Lofton - May 12, 2021 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)

Role
Director
Signature
/s/ Amy Kim by Power of Attorney for Kevin E. Lofton
Stock symbol
GILD
Transactions as of
May 12, 2021
Transactions value $
$0
Form type
4
Date filed
5/14/2021, 04:04 PM
Next filing
Jul 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award +2.22K +22.61% 12.1K May 12, 2021 Common Stock 2.22K Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +14.7K $0.00 14.7K May 12, 2021 Common Stock 14.7K $67.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.
F3 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.